A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma.
Rongkang LiChong LuWeiqiang YangYaqi ZhouJiatao ZhongXuan ChenXinji LiGuocheng HuangXiqi PengKaihao LiuChunduo ZhangHongyi HuYongqing LaiPublished in: Journal of clinical laboratory analysis (2022)
The three-miRNA panel (miR-29c-3p, miR-143-5p, and miR-205-5p) may become a novel non-invasive biological marker for nasopharyngeal cancer screening.